Endoluminal Suturing Devices Market
By Product;
Endoscopic Suturing Devices, Endovascular Suturing Devices, and ConsumablesBy Application;
Gastrointestinal Surgery, Bariatric Surgery, and Gastroesophageal Reflux Disease (GERD)By End Use;
Hospitals, Clinics, Ambulatory Surgical Centers, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Endoluminal Suturing Device Market Overview
Endoluminal Suturing Device Market (USD Million)
Endoluminal Suturing Device Market was valued at USD 16,015.92 million in the year 2024. The size of this market is expected to increase to USD 36,075.32 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 12.3%.
Endoluminal Suturing Devices Market
*Market size in USD million
CAGR 12.3 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 12.3 % |
Market Size (2024) | USD 16,015.92 Million |
Market Size (2031) | USD 36,075.32 Million |
Market Concentration | Low |
Report Pages | 359 |
Major Players
- Apollo Endosurgery, Inc.
- Johnson & Johnson
- Medtronic Plc
- Cook Group Incorporated
- USGI Medical
- Ovesco Endoscopy AG
- Endo Tools Therapeutics S.A.
- ErgoSuture
- Sutrue Ltd.
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Endoluminal Suturing Devices Market
Fragmented - Highly competitive market without dominant players
The Endoluminal Suturing Device Market is expanding rapidly as medical teams shift toward minimally invasive repair tools that reduce recovery time and enhance safety. Adoption rates have climbed by over 34%, driven by preference for less intrusive procedures. Providers are actively exploring product strategies that support advanced suturing workflows and stronger market expansion.
Precision Tools Fueled by Innovation
Innovative technological advancements like robotic suturing, single-use endoscopic systems, and automated needle deployment have increased demand by roughly 38%. These developments ensure high procedural accuracy and support complex anatomical repairs. Manufacturers focused on innovation are capitalizing on this trend to drive sustained growth.
Customization Elevates Clinical Adaptability
Demand for customizable endoluminal suturing systems has surged by over 31%, targeting specific procedural preferences and anatomical variations. Companies are investing in modular designs, dual-needle options, and ergonomic enhancements. This customization fortifies product innovation and helps create targeted, adaptable solutions that fuel market growth.
Digital Automation Defines Future Opportunities
The Endoluminal Suturing Device Market is trending toward digital-enabled and automated systems. Nearly 42% of developers are integrating AI-guided devices, real-time analytics, and cloud-based procedural tracking. This technological infusion supports efficient workflows, remote monitoring, and scalable expansion, setting a stage for advanced technological advancement.
Endoluminal Suturing Device Market Recent Developments
-
In June 2021, Ethicon, a Johnson & Johnson subsidiary and a market leader in flexible endoluminal robotics and soft tissue microwave ablation, declared that the National Institute for Health and Care Excellence (NICE) had recommended the use of its Plus Sutures according to its medical technology standards.
-
In December 2020, Apollo Endo-surgery, Inc. announced that Reshape Lifesciences would purchase its surgical product line for laparoscopic bariatric surgery. This acquisition increased Apollo's selection of endo-bariatric products.
Endoluminal Suturing Devices Market Segment Analysis
In this report, the Endoluminal Suturing Device Market has been segmented by Product, Application, End Use, and Geography.
Endoluminal Suturing Device Market, Segmentation by Product
The Endoluminal Suturing Device Market has been segmented by Product into Endoscopic Suturing Devices, Endovascular Suturing Devices, and Consumables.
Endoscopic Suturing Devices
Endoscopic suturing devices dominate the market, accounting for approximately 50% share due to their minimally invasive nature and growing demand in bariatric and gastrointestinal procedures. These devices offer enhanced precision and safety in internal tissue approximation during endoscopic interventions. Increasing adoption in outpatient and ambulatory settings further contributes to their market expansion.
Endovascular Suturing Devices
Endovascular suturing devices hold a significant portion of the market, contributing to nearly 30% of the total share. These devices are widely used for vascular closure following minimally invasive procedures such as EVAR or TAVR. Advancements in vascular sealing technologies and the rising prevalence of cardiovascular disorders are key factors driving growth in this segment.
Consumables
Consumables, including sutures, cartridges, and other accessories, make up around 20% of the market. Despite being support components, their recurring demand ensures a steady revenue stream. The increasing volume of endoscopic and endovascular procedures boosts the need for these essential consumables, making them critical to procedural efficacy and device compatibility.
Endoluminal Suturing Device Market, Segmentation by Application
The Endoluminal Suturing Device Market has been segmented by Application into Gastrointestinal surgery, Bariatric surgery and Gastroesophageal Reflux Disease (GERD).
Gastrointestinal Surgery
Gastrointestinal surgery is a major application area, representing nearly 45% of the endoluminal suturing device market. These devices are increasingly used in procedures involving colorectal, esophageal, and intestinal repairs due to their ability to perform precise and minimally invasive suturing. The growing prevalence of digestive tract disorders and a shift toward endoscopic treatments are fueling demand in this segment.
Bariatric Surgery
Bariatric surgery accounts for approximately 35% of the market share, driven by the global surge in obesity rates. Endoluminal suturing devices are vital in procedures like endoscopic sleeve gastroplasty, offering a non-surgical alternative for weight loss. Their ability to reduce complications and hospital stays makes them increasingly preferred in both developed and emerging markets.
Gastroesophageal Reflux Disease (GERD)
The use of endoluminal suturing devices in treating Gastroesophageal Reflux Disease (GERD) is growing steadily, contributing about 20% to the overall application share. These devices are employed in endoscopic fundoplication and other anti-reflux procedures that eliminate the need for invasive surgery. Rising awareness of GERD and a preference for minimally invasive interventions are accelerating their adoption in this segment.
Endoluminal Suturing Device Market, Segmentation by End Use
The Endoluminal Suturing Device Market has been segmented by End Use into Hospitals, Clinics, Ambulatory Surgical Centers and Others.
HospitalsHospitals represent the largest end-use segment, contributing to nearly 50% of the market share. Their advanced infrastructure, skilled personnel, and higher patient volume make them the primary choice for performing complex endoscopic and endovascular procedures. The availability of integrated surgical suites and post-operative care facilities further supports their dominance in the market.
ClinicsClinics hold around 20% of the market share, driven by their growing role in outpatient care and gastrointestinal diagnostics. These facilities are increasingly adopting endoluminal suturing devices for minor procedures due to their cost-effectiveness and shorter recovery times. The demand is particularly strong in urban and suburban areas with access to skilled endoscopists.
Ambulatory Surgical CentersAmbulatory Surgical Centers (ASCs) account for approximately 25% of the market. ASCs benefit from the rising demand for same-day procedures and the shift toward minimally invasive surgeries. These centers offer reduced hospital stays and lower costs, making them an attractive alternative for procedures involving endoluminal suturing devices.
OthersThe Others category, including academic institutes and specialty treatment centers, makes up the remaining 5% of the market. Though smaller in share, these facilities contribute to technological advancements and training for endoluminal techniques. Their role in research and device testing supports long-term market innovation and development.
Endoluminal Suturing Device Market, Segmentation by Geography
In this report, the Endoluminal Suturing Device Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Endoluminal Suturing Device Market Share (%), by Geographical Region
North AmericaNorth America holds the largest share of the global market at approximately 40%, driven by high adoption of minimally invasive procedures, strong healthcare infrastructure, and frequent technological advancements. The presence of key players and favorable reimbursement policies further accelerate the regional demand for endoluminal suturing devices.
EuropeEurope accounts for nearly 25% of the market, fueled by a growing geriatric population and increased prevalence of gastrointestinal disorders. Countries such as Germany, France, and the UK are investing in advanced endoscopic technologies, with rising clinical awareness enhancing device uptake in both public and private hospitals.
Asia PacificAsia Pacific is emerging as the fastest-growing regional market, contributing around 20% of the global share. Rapid urbanization, growing medical tourism, and increasing healthcare investments in countries like china, India, and Japan are driving the adoption of endoluminal suturing technologies. Expanding access to skilled endoscopic procedures also supports market growth.
Middle East and AfricaMiddle East and Africa represent a smaller but steadily expanding segment, holding nearly 8% of the market. The demand is primarily concentrated in the Gulf Cooperation Council (GCC) countries, where infrastructure development and rising awareness of advanced surgical techniques are supporting adoption. However, limited access to trained professionals and equipment remains a challenge in some areas.
Latin AmericaLatin America contributes about 7% to the global market. Countries like Brazil and Mexico are witnessing gradual growth due to increasing investment in healthcare modernization and a rising burden of obesity-related disorders. Expanding insurance coverage and improved access to endoscopic interventions are also aiding market penetration.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Endoluminal Suturing Device Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Rising gastrointestinal issues drive demand
- Advanced technology improves suturing devices
- Endoscopic procedures are favored for lower risks
-
Aging populations globally increase gastrointestinal treatment needs -The aging population trend globally has led to a notable increase in gastrointestinal treatment needs. With advancing age, individuals often experience a higher prevalence of gastrointestinal issues such as ulcers, diverticulitis, and hemorrhoids. These conditions can significantly impact the quality of life of older adults, leading to discomfort, pain, and in some cases, serious complications.
Age-related changes in the digestive system, such as decreased digestive enzyme production and slower gastrointestinal motility, can exacerbate existing gastrointestinal disorders or predispose individuals to new ones. As the proportion of elderly individuals continues to grow worldwide, healthcare systems face greater demand for gastrointestinal treatments, including both medical management and surgical interventions. Addressing the specific needs of aging populations requires comprehensive healthcare strategies that prioritize early detection, tailored treatment approaches, and ongoing management to ensure optimal outcomes and improved quality of life for older adults.
Restraints
- Shortage of trained professionals in suturing techniques
- Concerns exist about safety and effectiveness in complex cases
-
Lack of awareness about suturing as a treatment option -Suturing, or surgical stitching, is a common technique used in gastrointestinal surgeries to repair tissue damage, close wounds, and promote healing. Misconceptions or limited understanding about suturing may lead patients to pursue alternative treatment options or delay seeking medical care altogether. Healthcare professionals may not always consider suturing as a primary treatment modality, opting instead for other interventions such as medication or endoscopic procedures.
This lack of awareness about the benefits and efficacy of suturing in gastrointestinal conditions represents a significant barrier to optimal patient care and underscores the need for targeted educational initiatives aimed at both patients and healthcare providers. By increasing awareness and understanding of suturing as a safe and effective treatment option, patients can make more informed decisions about their healthcare, while doctors can enhance their treatment strategies to better meet the needs of their patients, ultimately improving patient outcomes and satisfaction.
Opportunities
- Expand training programs for healthcare workers
- Collaborate with institutions for research
- Implement AI and robotics for precise suturing
-
Educate patients and doctors about suturing benefits - For doctors, comprehensive education about suturing techniques and materials is essential for achieving successful surgical outcomes and reducing the risk of complications. Proper suturing ensures wound closure with minimal tension, which is crucial for promoting proper tissue healing and reducing the likelihood of wound dehiscence or infection. By educating doctors about the various types of sutures available, as well as their indications and best practices for use, healthcare providers can optimize their suturing approach to meet the specific needs of each patient and procedure.
Educating doctors about the importance of proper wound assessment and selection of appropriate suturing techniques based on factors such as wound location, depth, and tension level, enables them to make informed decisions and customize their approach to wound closure. Patient and doctor education about suturing benefits fosters collaboration and communication, leading to improved patient satisfaction, faster recovery, and better surgical outcomes.
Competitive Landscape Analysis
Key players in Global Endoluminal Suturing Device Market include
- Apollo Endosurgery, Inc.
- Johnson & Johnson
- Medtronic Plc
- Cook Group Incorporated
- USGI Medical
- Ovesco Endoscopy AG
- Endo Tools Therapeutics S.A.
- ErgoSuture
- Sutrue Ltd.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By End Use
- Market Snapshot, By Region
- Endoluminal Suturing Device Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Rising gastrointestinal issues drive demand
- Advanced technology improves suturing devices
- Endoscopic procedures are favored for lower risks
- Aging populations globally increase gastrointestinal treatment needs
- Restraints
- Shortage of trained professionals in suturing techniques
- Concerns exist about safety and effectiveness in complex cases
- Lack of awareness about suturing as a treatment option
- Opportunities
- Expand training programs for healthcare workers
- Collaborate with institutions for research
- Implement AI and robotics for precise suturing
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Endoluminal Suturing Device Market, By Product, 2021 - 2031 (USD Million)
- Endoscopic Suturing Devices
- Endovascular Suturing Devices
- Consumables
- Endoluminal Suturing Device Market, By Application, 2021 - 2031 (USD Million)
- Gastrointestinal Surgery
- Bariatric Surgery
- Gastroesophageal Reflux Disease (GERD)
- Endoluminal Suturing Device Market, By End Use, 2021 - 2031 (USD Million)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- Endoluminal Suturing Device Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Endoluminal Suturing Device Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape Analysis
- Company Profiles
- Apollo Endosurgery, Inc.
- Johnson & Johnson
- Medtronic Plc
- Cook Group Incorporated
- USGI Medical
- Ovesco Endoscopy AG
- Endo Tools Therapeutics S.A.
- ErgoSuture
- Sutrue Ltd.
- Company Profiles
- Analyst Views
- Future Outlook of the Market